250 related articles for article (PubMed ID: 26295496)
1. Mitochondria and DNA Targeting of 5,10,15,20-Tetrakis(7-sulfonatobenzo[b]thiophene) Porphyrin-Induced Photodynamic Therapy via Intrinsic and Extrinsic Apoptotic Cell Death.
Rangasamy S; Ju H; Um S; Oh DC; Song JM
J Med Chem; 2015 Sep; 58(17):6864-74. PubMed ID: 26295496
[TBL] [Abstract][Full Text] [Related]
2. Meso-tetrakis(p-sulfonatophenyl)N-confused porphyrin tetrasodium salt: a potential sensitizer for photodynamic therapy.
Thomas AP; Saneesh Babu PS; Asha Nair S; Ramakrishnan S; Ramaiah D; Chandrashekar TK; Srinivasan A; Radhakrishna Pillai M
J Med Chem; 2012 Jun; 55(11):5110-20. PubMed ID: 22582931
[TBL] [Abstract][Full Text] [Related]
3. Cell death mechanistic study of photodynamic therapy against breast cancer cells utilizing liposomal delivery of 5,10,15,20-tetrakis(benzo[b]thiophene) porphyrin.
Nam G; Rangasamy S; Ju H; Samson AA; Song JM
J Photochem Photobiol B; 2017 Jan; 166():116-125. PubMed ID: 27889618
[TBL] [Abstract][Full Text] [Related]
4. Photolon™ --photosensitization induces apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes.
Ali-Seyed M; Bhuvaneswari R; Soo KC; Olivo M
Int J Oncol; 2011 Oct; 39(4):821-31. PubMed ID: 21725591
[TBL] [Abstract][Full Text] [Related]
5. Lysosomal cathepsin initiates apoptosis, which is regulated by photodamage to Bcl-2 at mitochondria in photodynamic therapy using a novel photosensitizer, ATX-s10 (Na).
Ichinose S; Usuda J; Hirata T; Inoue T; Ohtani K; Maehara S; Kubota M; Imai K; Tsunoda Y; Kuroiwa Y; Yamada K; Tsutsui H; Furukawa K; Okunaka T; Oleinick NL; Kato H
Int J Oncol; 2006 Aug; 29(2):349-55. PubMed ID: 16820876
[TBL] [Abstract][Full Text] [Related]
6. Combination treatment with photodynamic therapy and curcumin induces mitochondria-dependent apoptosis in AMC-HN3 cells.
Ahn JC; Kang JW; Shin JI; Chung PS
Int J Oncol; 2012 Dec; 41(6):2184-90. PubMed ID: 23064512
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy-induced death of MCF-7 human breast cancer cells: a role for caspase-3 in the late steps of apoptosis but not for the critical lethal event.
Xue LY; Chiu SM; Oleinick NL
Exp Cell Res; 2001 Feb; 263(1):145-55. PubMed ID: 11161713
[TBL] [Abstract][Full Text] [Related]
8. Zinc-(II) 2,9,16,23-tetrakis (methoxy) phthalocyanine: potential photosensitizer for use in photodynamic therapy in vitro.
Yslas EI; Durantini EN; Rivarola VA
Bioorg Med Chem; 2007 Jul; 15(13):4651-60. PubMed ID: 17467998
[TBL] [Abstract][Full Text] [Related]
9. Methylene blue-mediated photodynamic therapy induces mitochondria-dependent apoptosis in HeLa cell.
Lu Y; Jiao R; Chen X; Zhong J; Ji J; Shen P
J Cell Biochem; 2008 Dec; 105(6):1451-60. PubMed ID: 18980251
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy of prostate cancer using porphyrinic formulations.
Mesquita MQ; Ferreira AR; Neves MDGPMS; Ribeiro D; Fardilha M; Faustino MAF
J Photochem Photobiol B; 2021 Oct; 223():112301. PubMed ID: 34492530
[TBL] [Abstract][Full Text] [Related]
11. Involvement of the mitochondria-caspase pathway in HeLa cell death induced by 2-ethanolamino-2-demethoxy-17-ethanolimino-hypocrellin B (EAHB)-mediated photodynamic therapy.
Zhou Z; Zhao C; Liu W; Li Q; Zhang L; Sheng W; Li Z; Zeng Y; Zhong R
Int J Toxicol; 2012; 31(5):483-92. PubMed ID: 23008347
[TBL] [Abstract][Full Text] [Related]
12. Photocytotoxicity, cellular uptake and subcellular localization of amidinophenylporphyrins as potential photodynamic therapeutic agents: An in vitro cell study.
Zhu S; Wu F; Wang K; Zheng Y; Li Z; Zhang X; Wong WK
Bioorg Med Chem Lett; 2015 Oct; 25(20):4513-7. PubMed ID: 26338364
[TBL] [Abstract][Full Text] [Related]
13. Efficiency of photodynamic therapy on WM35 melanoma with synthetic porphyrins: Role of chemical structure, intracellular targeting and antioxidant defense.
Baldea I; Olteanu DE; Bolfa P; Ion RM; Decea N; Cenariu M; Banciu M; Sesarman AV; Filip AG
J Photochem Photobiol B; 2015 Oct; 151():142-52. PubMed ID: 26257158
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial reactive oxygen species and nitric oxide-mediated cancer cell apoptosis in 2-butylamino-2-demethoxyhypocrellin B photodynamic treatment.
Lu Z; Tao Y; Zhou Z; Zhang J; Li C; Ou L; Zhao B
Free Radic Biol Med; 2006 Nov; 41(10):1590-605. PubMed ID: 17045927
[TBL] [Abstract][Full Text] [Related]
15. Benzamide porphyrins with directly conjugated and distal pyridyl or pyridinium groups substituted to the porphyrin macrocycles: Study of the photosensitising abilities as inducers of apoptosis in cancer cells under photodynamic conditions.
Sengupta D; Mazumdar ZH; Mukherjee A; Sharma D; Halder AK; Basu S; Jha T
J Photochem Photobiol B; 2018 Jan; 178():228-236. PubMed ID: 29156351
[TBL] [Abstract][Full Text] [Related]
16. Efficient induction of apoptosis in HeLa cells by a novel cationic porphycene photosensitizer.
Ruiz-González R; Acedo P; Sánchez-García D; Nonell S; Cañete M; Stockert JC; Villanueva A
Eur J Med Chem; 2013 May; 63():401-14. PubMed ID: 23517729
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, characterization, and photodynamic therapy activity of 5,10,15,20-Tetrakis(carboxyl)porphyrin.
Zhang Z; Yu HJ; Wu S; Huang H; Si LP; Liu HY; Shi L; Zhang HT
Bioorg Med Chem; 2019 Jun; 27(12):2598-2608. PubMed ID: 30992204
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and in vitro biological evaluation of lipophilic cation conjugated photosensitizers for targeting mitochondria.
Rajaputra P; Nkepang G; Watley R; You Y
Bioorg Med Chem; 2013 Jan; 21(2):379-87. PubMed ID: 23245573
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and photobiological study of a novel chlorin photosensitizer BCPD-18MA for photodynamic therapy.
Zhang J; Deng L; Yao J; Gu P; Yang F; Wang X; Liu W; Zhang Y; Ke X; Jing X; Chen J
Bioorg Med Chem; 2011 Sep; 19(18):5520-8. PubMed ID: 21855352
[TBL] [Abstract][Full Text] [Related]
20. Subcellular localization of Photofrin determines the death phenotype of human epidermoid carcinoma A431 cells triggered by photodynamic therapy: when plasma membranes are the main targets.
Hsieh YJ; Wu CC; Chang CJ; Yu JS
J Cell Physiol; 2003 Mar; 194(3):363-75. PubMed ID: 12548556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
